Vivek Kaushal to Neoadjuvant Therapy
This is a "connection" page, showing publications Vivek Kaushal has written about Neoadjuvant Therapy.
Connection Strength
0.183
-
Immune checkpoint inhibitors as neoadjuvant therapy in early triple-negative breast cancer: A systematic review and meta-analysis. J Cancer Res Ther. 2022 Oct-Dec; 18(6):1754-1765.
Score: 0.183